Alejandro Labastida‐Ramírez

Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system

Alejandro Labastida‐Ramírez, Eloísa Rubio‐Beltrán, Kristian Agmund Haanes et al. · Pain · 2020 · 94 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Characterization of binding, functional activity, and contractile responses of the selective 5‐HT_1F receptor agonist lasmiditan

Eloísa Rubio‐Beltrán, Alejandro Labastida‐Ramírez, Kristian Agmund Haanes et al. · British Journal of Pharmacology · 2019 · 74 citations · Full text

Medicine, Cardiology, Pharmacology +17

Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models

Kristian Agmund Haanes, Alejandro Labastida‐Ramírez, Frank W. Blixt et al. · Cephalalgia · 2019 · 46 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteries

Eloísa Rubio‐Beltrán, Alejandro Labastida‐Ramírez, Kristian Agmund Haanes et al. · Cephalalgia · 2019 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Characterization of the trigeminovascular actions of several adenosine A2A receptor antagonists in an in vivo rat model of migraine

Kristian Agmund Haanes, Alejandro Labastida‐Ramírez, Kayi Y. Chan et al. · The Journal of Headache and Pain · 2018 · 22 citations · Full text

Medicine, Neuroscience, Pharmacology +9